Ronald Eastman

Director/Board Member chez EPIPHANY TECHNOLOGY ACQUISITION CORP.

Profil

Ronald Welcome Eastman is currently the Vice Chairman at BioPlus Acquisition Corp.
He is also a Director at IntegenX, Inc., Medical, Inc., Suneva Medical, Inc., Juvenile Diabetes Research Foundation of Arizona, Inc., and an Independent Director at Epiphany Technology Acquisition Corp.
and Enterprise 4.0 Technology Acquisition Corp.
Additionally, he serves as a Senior Advisor at Essex Woodlands Management, Inc. Mr. Eastman previously held positions as the Chief Executive Officer at Geron Corp.
and Rinat Neuroscience Corp.
He was also a Managing Director & Managing Partner at EW Healthcare Partners Fund.
Furthermore, he has served as an Independent Director at Revance Therapeutics, Inc., EyePoint Pharmaceuticals, Inc., and Corium International, Inc. Mr. Eastman has an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Williams College.

Postes actifs de Ronald Eastman

Sociétés	Poste	Début
BIOPLUS ACQUISITION CORP.	Director/Board Member	01/12/2021
EPIPHANY TECHNOLOGY ACQUISITION CORP.	Director/Board Member	23/09/2022
ENTERPRISE 4.0 TECHNOLOGY ACQUISITION CORP.	Director/Board Member	21/04/2023
Medical, Inc.	Director/Board Member	-
Essex Woodlands Management, Inc.	Private Equity Investor	01/10/2006
Suneva Medical, Inc.	Director/Board Member	01/01/2016
Juvenile Diabetes Research Foundation of Arizona, Inc.	Director/Board Member	-
IntegenX, Inc.	Director/Board Member	-

Anciens postes connus de Ronald Eastman

Sociétés	Poste	Fin
EYEPOINT PHARMACEUTICALS, INC.	Director/Board Member	23/06/2022
░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	-

Formation de Ronald Eastman

The Trustees of Columbia University in The City of New York	Masters Business Admin
Williams College	Undergraduate Degree